@article{AkhoonGuptaTiwarietal.2019,
  author    = {Akhoon, Bashir A. and Gupta, Shishir K. and Tiwari, Sudeep and Rathor, Laxmi and Pant, Aakanksha and Singh, Nivedita and Gupta, Shailendra K. and Dandekar, Thomas and Pandey, Rakesh},
  title     = {C. elegans protein interaction network analysis probes RNAi validated pro-longevity effect of nhr-6, a human homolog of tumor suppressor Nr4a1},
  series = {Scientific Reports},
  volume    = {9},
  journal   = {Scientific Reports},
  doi       = {10.1038/s41598-019-51649-0},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-202666},
  pages     = {15711},
  year      = {2019},
  abstract  = {Protein-protein interaction (PPI) studies are gaining momentum these days due to the plethora of various high-throughput experimental methods available for detecting PPIs. Proteins create complexes and networks by functioning in harmony with other proteins and here in silico network biology hold the promise to reveal new functionality of genes as it is very difficult and laborious to carry out experimental high-throughput genetic screens in living organisms. We demonstrate this approach by computationally screening C. elegans conserved homologs of already reported human tumor suppressor and aging associated genes. We select by this nhr-6, vab-3 and gst-23 as predicted longevity genes for RNAi screen. The RNAi results demonstrated the pro-longevity effect of these genes. Nuclear hormone receptor nhr-6 RNAi inhibition resulted in a C. elegans phenotype of 23.46\% lifespan reduction. Moreover, we show that nhr-6 regulates oxidative stress resistance in worms and does not affect the feeding behavior of worms. These findings imply the potential of nhr-6 as a common therapeutic target for aging and cancer ailments, stressing the power of in silico PPI network analysis coupled with RNAi screens to describe gene function.},
  language  = {en}
}
@phdthesis{ALHijailan2019,
  author    = {AL-Hijailan, Reem Saud},
  title     = {Establishment of endothelialized cardiac tissue using human induced pluripotent stem cells generated cardiomyocytes},
  doi       = {10.25972/OPUS-17397},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-173979},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Cardiovascular diseases are considered the leading cause of death worldwide according to the World Health Organization. Heart failure is the last stage of most of these diseases, where loss of myocardium leads to architectural and functional decline. The definitive treatment option for patients with CVDs is organ or tissue transplantation, which relies on donor availability. Therefore, generating an autologous bioengineered myocardium or heart could overcome this limitation. In addition, generating cardiac patches will provide ventricular wall support and enable reparative stem cells delivery to damaged areas. Although many hurdles still exist, a good number of researches have attempted to create an engineered cardiac tissue which can induce endogenous cardiac repair by replacing damaged myocardium. The present study provided cardiac patches in two models, one by a detergent coronary perfusion decellularization protocol that was optimized, and the other that resulted in a 3D cell-free extracellular matrix with intact architecture and preserved s-glycosaminoglycan and vasculature conduits. Perfusion with 1\% Sodium dodecyle sulfate (SDS) under constant pressure resulted in cell-free porcine scaffold within two and cell-free rat scaffold in 7 days, whereas scaffold perfused with 4\% sodium deoxycholate (SDO) was not able to remove cells completely. Re-reendothelialization of tissue vasculature was obtained by injecting human microvascular endothelial cell and human fibroblast in 2:1 ratio in a dynamic culture. One-week later, CD31 positive cells and endothelium markers were observed, indicating new blood lining. Moreover, functionality test of re-endothelialized tissue revealed improvement in clotting seen in decellularized tissues. When the tissue was ready to be repopulated, porcine induced pluripotent stem cells (PiPSc) were generated by transfected reprogramming of porcine skin fibroblast and then differentiated to cardiac cells following a robust protocol, for an autologous cardiac tissue model. However, due to the limitation in the PiPSc cell number, alternatively, human induced pluripotent stem cells generated cardiac cells were used. For reseeding a coculture of human iPSc generated cardiac cells, human mesenchymal stem cells and human fibroblast in 2:1:1 ratio respectively were used in a dynamic culture for 6-8 weeks. Contractions at different areas of the tissue were recorded at an average beating rate of 67 beats/min. In addition, positive cardiac markers (Troponin T), Fibroblast (vemintin), and mesenchymal stem cells (CD90) were detected. Not only that, but by week 3, MSC started differentiating to cardiac cells progressively until few CD90 positive cells were very few by week 6 with increasing troponin t positive cells in parallel. Electrophysiological and drug studies were difficult to obtain due to tissue thickness and limited assessment sources. However, the same construct was established using small intestine submucosa (SISer) scaffold, which recorded a spontaneous beating rate between 0.88 and 1.2 Hz, a conduction velocity of 23.9 ± 0.74 cm s-1, and a maximal contraction force of 0.453 ± 0.015 mN. Moreover, electrophysiological studies demonstrated a drug-dependent response on beating rate; a higher adrenalin frequency was revealed in comparison to the untreated tissue and isoproterenol administration, whereas a decrease in beating rate was observed with propranolol and untreated tissue. The present study demonstrated the establishment of vascularized cardiac tissue, which can be used for human clinical application.},
  language  = {en}
}
@phdthesis{Anany2019,
  author    = {Anany, Mohamed Ahmed Mohamed Mohamed},
  title     = {Enhancement of Toll-like receptor3 (TLR3)-induced death signaling by TNF-like weak inducer of apoptosis (TWEAK)},
  doi       = {10.25972/OPUS-18975},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-189757},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is a member of the TNF superfamily (TNFSF) and is as such initially expressed as type II class transmembrane glycoprotein from which a soluble ligand form can be released by proteolytic processing. While the expression of TWEAK has been detected at the mRNA level in various cell lines and cell types, its cell surface expression has so far only been documented for dendritic cells, monocytes and interferon-γ stimulated NK cells. The fibroblast growth factor-inducible-14 (Fn14) is a TRAF2-interacting receptor of the TNF receptor superfamily (TNFRSF) and is the only receptor for TWEAK. The expression of Fn14 is strongly induced in a variety of non-hematopoietic cell types after tissue injury. The TWEAK/Fn14 system induces pleiotropic cellular activities such as induction of proinflammatory genes, stimulation of cellular angiogenesis, proliferation, differentiation, migration and in rare cases induction of apoptosis. On the other side, Toll-like receptor3 (TLR3) is one of DNA- and RNA-sensing pattern recognition receptors (PRRs), plays a crucial role in the first line of defense against virus and invading foreign pathogens and cancer cells. Polyinosinic-polycytidylic acid poly(I:C) is a synthetic analog of dsRNA, binds to TLR3 which acts through the adapter TRIF/TICAM1, leading to cytokine secretion, NF-B activation, IRF3 nuclear translocation, inflammatory response and may also elicit the cell death. TWEAK sensitizes cells for TNFR1-induced apoptosis and necroptosis by limiting the availability of protective TRAF2-cIAP1 and TRAF2-cIAP2 complexes, which interact with the TNFR1-binding proteins TRADD and RIPK1. In accordance with the fact that poly(I:C)-induced signaling also involves these proteins, we found enhanced necroptosis-induction in HaCaT and HeLa-RIPK3 by poly(I:C) in the presence of TWEAK (Figure 24). Analysis of a panel of TRADD, FADD, RIPK1 and caspase-8 knockout cells revealed furthermore similarities and differences in the way how these molecules act in cell death signaling by poly(I:C)/TWEAK and TNF and TRAIL. RIPK1 turned out to be essential for poly(I:C)/TWEAK-induced caspase-8-mediated apoptosis but was dispensable for these responses in TNF and TRAIL signaling. Lack of FADD protein abrogated TRAIL- but not TNF- and poly(I:C)-induced necroptosis. Moreover, we observed that both long and short FLIP rescued HaCaT and HeLa-RIPK3 cells from poly(I:C)-induced apoptosis or necroptosis. To sum up, our results demonstrate that TWEAK, which is produced by interferon stimulated myeloid cells, controls the induction of apoptosis and necroptosis by the TLR3 ligand poly(I:C) and may thus contribute to cancer or anti-viral immunity treatment.},
  subject      = {Immunologe},
  language  = {en}
}
@article{AnnunziatavandeVlekkertWolfetal.2019,
  author    = {Annunziata, Ida and van de Vlekkert, Diantha and Wolf, Elmar and Finkelstein, David and Neale, Geoffrey and Machado, Eda and Mosca, Rosario and Campos, Yvan and Tillman, Heather and Roussel, Martine F. and Weesner, Jason Andrew and Fremuth, Leigh Ellen and Qiu, Xiaohui and Han, Min-Joon and Grosveld, Gerard C. and d'Azzo, Alessandra},
  title     = {MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat},
  series = {Nature Communications},
  volume    = {10},
  journal   = {Nature Communications},
  doi       = {10.1038/s41467-019-11568-0},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-221189},
  year      = {2019},
  abstract  = {Coordinated regulation of the lysosomal and autophagic systems ensures basal catabolism and normal cell physiology, and failure of either system causes disease. Here we describe an epigenetic rheostat orchestrated by c-MYC and histone deacetylases that inhibits lysosomal and autophagic biogenesis by concomitantly repressing the expression of the transcription factors MiT/TFE and FOXH1, and that of lysosomal and autophagy genes. Inhibition of histone deacetylases abates c-MYC binding to the promoters of lysosomal and autophagy genes, granting promoter occupancy to the MiT/TFE members, TFEB and TFE3, and/or the autophagy regulator FOXH1. In pluripotent stem cells and cancer, suppression of lysosomal and autophagic function is directly downstream of c-MYC overexpression and may represent a hallmark of malignant transformation. We propose that, by determining the fate of these catabolic systems, this hierarchical switch regulates the adaptive response of cells to pathological and physiological cues that could be exploited therapeutically.},
  language  = {en}
}
@phdthesis{Awad2019,
  author    = {Awad, Eman Da'as},
  title     = {Modulation of insulin-induced genotoxicity in vitro and genomic damage in gestational diabetes},
  doi       = {10.25972/OPUS-16186},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-161866},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Diabetes mellitus is a global health problem, where the risk of diabetes increases rapidly due to the lifestyle changes. Patients with type II diabetes have many complications with increased risk of morbidity and mortality. High levels of insulin may lead to DNA oxidation and damage. Several studies proposed that hyperinsulinemia may be an important risk factor for various types of cancer. To investigate insulin signaling pathway inducing oxidative stress and genomic damage, pharmaceutical and natural compounds which can interfere with the insulin pathway including PI3K inhibitors, resveratrol, lovastatin, and RAD-001 were selected due to their beneficial effects against metabolic disorder. Thus, the anti-genotoxic potential of these compounds regarding insulin-mediated oxidative stress were investigated in normal rat kidney cells in vitro. Our compounds showed protective effect against genotoxic damage and significantly decreased reactive oxygen specious after treatment of cells with insulin with different mechanisms of protection between the compounds. Thus, these compounds may be attractive candidates for future support of diabetes mellitus therapy. Next, we explored the link between gestational diabetes mellitus and genomic damage in cells derived from human blood. Moreover, we investigated the influence of estradiol, progesterone, adrenaline and triiodothyronine on insulin-induced genomic damage in vitro. First, we studied the effect of these hormones in human promyelocytic leukemia cells and next ex vivo with non-stimulated and stimulated peripheral blood mononuclear cells. In parallel, we also measured the basal genomic damage using three conditions (whole blood, non-stimulated and stimulated peripheral blood mononuclear cells) in a small patient study including non-pregnant controls with/without hormonal contraceptives, with a subgroup of obese women, pregnant women, and gestational diabetes affected women. A second-time point after delivery was also applied for analysis of the blood samples. Our results showed that GDM subjects and obese individuals exhibited higher basal DNA damage compared to lower weight nonpregnant or healthy pregnant women in stimulated peripheral blood mononuclear cells in both comet and micronucleus assays. On the other hand, the DNA damage in GDM women had decreased at two months after birth. Moreover, the applied hormones also showed an influence in vitro in the enhancement of the genomic damage in cells of the control and pregnant groups but this damage did not exceed the damage which existed in obese and gestational diabetes mellitus patients with high level of genomic damage. In conclusion, insulin can induce genomic damage in cultured cells, which can be modulated by pharmaceutical and naturals substances. This may be for future use in the protection of diabetic patients, who suffer from hyperinsulinemia during certain disease stages. A particular form of diabetes, GDM, was shown to lead to elevated DNA damage in affected women, which is reduced again after delivery. Cells of affected women do not show an enhanced, but rather a reduced sensitivity for further DNA damage induction by hormonal treatment in vitro. A potential reason may be an existence of a maximally inducible damage by hormonal influences.},
  subject      = {Gestationsdiabetes},
  language  = {en}
}
@phdthesis{Bach2019,
  author    = {Bach, Matthias},
  title     = {Massenspektrometrische Analyse der Interaktionen von Protein mit Proteinen und Proteinen mit niedermolekularen Verbindungen},
  doi       = {10.25972/OPUS-16046},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-160462},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Proteine k{\"o}nnen aufgrund ihrer biochemischen Vielfalt eine Vielzahl von Interaktionen mit anderen Proteinen oder chemischen Verbindungen eingehen. Im ersten Teil dieser Arbeit wurden Protein-Protein Interaktionen mittels chemischen Quervernetzens untersucht. Das Ziel war, neue und verbesserte Methoden zu entwickeln, um Interaktionsnetzwerke zu erstellen. Im zweiten Teil wurden die Interaktionen von Proteinen mit niedermolekularen Verbindungen untersucht, um Drug Targets zu identifizieren und zu validieren. Die Untersuchung von Protein-Protein Interaktionen mittels Massenspektrometrie (MS) ist eine leistungsf{\"a}hige Methode, um alle potentiellen Interaktionen eines Proteins nach einer Anreicherung (Co-IP) aus einem Zelllysat zu detektieren. Durch das zus{\"a}tzliche Quervernetzen dieser Proteine und anschließender MS kann ein Interaktionsnetzwerk erstellt werden, um direkte von indirekten Interaktionen unterscheiden zu k{\"o}nnen (Topology Mapping). Zur Methodenetablierung wurden kommerzielle Crosslinker und rekombinante Proteine von bekannten Interaktionspartnern mit niedriger Komplexit{\"a}t verwendet. Die beiden Interaktionspartner NPL4 und UFD1 konnten mit dem Crosslinker BS3 erfolgreich quervernetzt und anhand der vernetzten Peptide identifiziert werden. Im n{\"a}chsten Schritt wurde dieser Arbeitsablauf auf eine Co-IP des Mediatorkomplexes aus Hefe angewendet. Die Probenkomplexit{\"a}t ist hierbei 500 - 1000-fach h{\"o}her als bei der Verwendung von rekombinanten Proteinen. Nach der erfolgreichen Quervernetzung konnte innerhalb des Komplexes ein Interaktionsnetzwerk erstellt werden. Diese Daten passen zu dem bereits bekannten Modell des Mediatorkomplexes. Interaktionen zu bekannten Interaktionspartnern, wie der RNA-Pol II, konnten aufgrund deren subst{\"o}chiometrischen Anreicherung nicht identifiziert werden. Aufgrund der genannten Limitationen beim Quervernetzen von Proteinen wurden folgende neue und verbesserte Methoden entwickelt: 1. Verwendung des spaltbaren Crosslinkers (DSSO), der w{\"a}hrend der Messung selektiv durch niedrige Kollisionsenergie gespalten werden kann, um die Datenbanksuche zu vereinfachen. Die Funktionalit{\"a}t der DSSO-Strategie konnte erfolgreich am Protein Cytochrom C getestet werden. Bei der ersten Fragmentierung wird der Linker gespalten, anschließend k{\"o}nnen die getrennten Peptide separat fragmentiert werden. Die erzeugten Daten sind mit einer Standarddatenbanksuche kompatibel, was bei gemischten Spektren von zwei Peptiden nicht der Fall w{\"a}re. Beim Quervernetzen der rekombinanten Interaktionspartner UBX und p97N mit DSSO konnte der zu best{\"a}tigende Crosslink zwischen zwei Lysinen nicht identifziert werden. Grund hierf{\"u}r k{\"o}nnte eine zu kurze Linkerl{\"a}nge von DSSO sein. Diese Versuche brachten jedoch einige Limitationen des Ansatzes zum Vorschein, wie die Beschr{\"a}nkung auf die Protease Trypsin, aufgrund der positiven Ladung am C-Terminus und die Notwendigkeit von großen Proteinmengen, da das Spalten des Linkers einen zus{\"a}tzlichen Intensit{\"a}tsverlust f{\"u}r die folgende Identifizierung der Peptide mit sich bringt. 2. Da die niedrige Abundanz von quervernetzten Peptiden das Hauptproblem bei deren Identifizierung ist, wurde eine Methode entwickelt, um w{\"a}hrend der Messung direkt nach diesen niedrig abundanten Spezies zu suchen. Entscheidendes Kriterium hierf{\"u}r war, dass quervernetzte Peptide zwei C-Termini haben. Diese wurden zur H{\"a}lfte enzymatisch mit 18O bzw. 16O markiert und wieder vereinigt. Der resultierende Massenunterschied von 8 Da (4 x 18O) kommt ausschließlich bei zwei quervernetzten Peptiden vor und kann w{\"a}hrend der Messung direkt gesucht werden. Die vollst{\"a}ndige Markierung von Peptiden mit 18O wurde zun{\"a}chst am Protein Beta-Galaktosidase getestet. Bereits hier stellte sich heraus, dass der enzymatische R{\"u}cktausch von 18O zu 16O ein Problem darstellt und die Markierungseffizienz von Aminos{\"a}uren beeinflusst wird, die sich C-terminal nach der Spaltstelle befinden. Mit dieser Strategie ließ sich somit keine vollst{\"a}ndige Markierung f{\"u}r alle Peptide erreichen, was f{\"u}r diese Strategie essentiell gewesen w{\"a}re. 3. Um alle Probleme zu umgehen, die bei der Identifizierung von quervernetzten Peptiden auftreten, wurde eine Methode entwickelt, um quervernetzte Proteine anhand von Profilen nach einer Auftrennung im Polyacrylamidgel (SDS-PAGE) zu identifizieren. Durch das Quervernetzen von Proteinen entstehen zus{\"a}tzliche Proteinbanden nach einer SDSPAGE, die im Gel nach oben verschoben sind. Alle Proteine in diesen neu erzeugten Bereichen stellen somit potentielle Interaktionspartner dar. Als Modellsystem wurde der Mediatorkomplex verwendet. Er wurde aus einem Zelllysat mittels Co-IP angereichert und anschließend quervernetzt. Aus den mittels LC-MS/MS gemessenen Gelfraktionen wurden Proteinprofile erstellt und miteinander verglichen. Die Intensit{\"a}tsmaxima der Proteine des Mediatorkomplexes konnten in bestimmten zus{\"a}tzlichen Fraktionen gefunden werden, was den indirekten Nachweis f{\"u}r eine Interaktion darstellt. Die Funktionalit{\"a}t der Strategie konnte somit best{\"a}tigt werden. Ein verbleibender Nachteil ist jedoch die zu geringe Trennleistung von Polyacrylamidgelen. Befinden sich mehr als 50 Proteine in einer Fraktion, k{\"o}nnen potentielle Interaktionspartner nicht eindeutig zu einer Untereinheit eines Komplexes zugeordnet werden. Im zweiten Teil der Arbeit wurde im Rahmen der Klinischen Forschergruppe 216 (CRU216) Interaktionen von Proteinen mit verschiedenen niedermolekularen Verbindungen massenspektrometrisch untersucht, um potentielle Drug Targets zu identifizieren. Diese Versuche sind vergleichbar mit Co-IP Experimenten, da sich der Arbeitsablauf nur durch die Anreicherung mittels chemischer Verbindung unterscheidet. Hierzu wurden biotinylierte Verbindungen immobilisiert und potentielle Drug Targets aus einem komplexen Zelllysat angereichert. Die Identifzierung der echten Bindungspartner wurde {\"u}ber quantitive Massenspektrometrie erreicht. Dabei wurden die angereicherten Proteine, die an die niedermolekularen Substanzen binden mit einer geeigneten Kontrollanreicherung verglichen. Mit den getesteten α-acyl Aminocarboxamiden konnten verschiedene Proteinkomplexe und interagierende Proteine spezifisch angereichert werden. Hierbei waren die vier Kinasen DNA-PK, ATM, ATR und mTOR besonders interessant, da sie mit onkogenem Signalling und {\"U}berlebensmechanismen wie der Hitzeschockantwort in Zellen des Multiplen Myeloms (MM) in Verbidnung stehen. Die Inhibition der DNA-PK, ATM, ATR und mTOR mit α- acyl Aminocarboxamiden stellt somit einen m{\"o}glichen Therapieansatz dar, wenn er zusammen mit hitzestressausl{\"o}senden Inhibitoren verwendet wird. Weiterhin konnte gezeigt werden, dass die Armadillodom{\"a}ne innerhalb der potentiellen Drug targets signifkant angereichert wurde. Sie stellt damit eine potentielle Bindestelle der α-acyl Aminocarboxamide dar. Abschließend wurden Proteine mit biotinylierten Naphtylisochinolinen aus einem MMZelllysat angereichert, deren Vorl{\"a}ufersubstanzen eine Wirkung auf Tumorzellen und den Malariaparasit Plasmodium falciparum gezeigt hatten. Hierbei konnten vor allem RNAbindende- und mRNA-Splicing Proteine identifiziert werden, die zum Teil essentiell f{\"u}r das Spleißen in-vivo sind. Hierzu geh{\"o}ren mehrere Untereinheiten der Splicing Factoren 3A und 3B. Die Ver{\"a}nderung der transkriptionellen Regulation und der resultierende Effekt auf Krebszellen konnte bereits in anderen Studien mit dem Inhibitor Spliceostatin A gezeigt werden, der das Spleißen beeinflusst.},
  subject      = {Massenspektrometrie},
  language  = {de}
}
@phdthesis{Baig2019,
  author    = {Baig, Ayesha Anjum},
  title     = {Studies on platelet interactions with the coagulation system and on modulators of platelet (hem)ITAM signaling in genetically modified mice},
  doi       = {10.25972/OPUS-16488},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-164888},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Activated platelets and coagulation jointly contribute to physiological hemostasis. However, pathological conditions can also trigger unwanted platelet activation and initiation of coagulation resulting in thrombosis and precipitation of ischemic damage of vital organs such as the heart or brain. The specific contribution of procoagulant platelets, positioned at the interface of the processes of platelet activation and coagulation, in ischemic stroke had remained uninvestigated. The first section of the thesis addresses this aspect through experiments conducted in novel megakaryocyte- and platelet-specific TMEM16F conditional KO mice (cKO). cKO platelets phenocopied defects in platelets from Scott Syndrome patients and had severely impaired procoagulant characteristics. This led to decelerated platelet-driven thrombin generation and delayed fibrin formation. cKO mice displayed prolonged bleeding times and impaired arterial thrombosis. However, infarct volumes in cKO mice were comparable to wildtype (WT) mice in an experimental model of ischemic stroke. Therefore, while TMEM16F-regulated platelet procoagulant activity is critical for hemostasis and thrombosis, it is dispensable for cerebral thrombo-inflammation in mice. The second section describes the generation and initial characterization of a novel knockin mouse strain that expresses human coagulation factor XII (FXII) instead of endogenous murine FXII. These knockin mice had normal occlusion times in an experimental model of arterial thrombosis demonstrating that human FXII is functional in mice. Therefore, these mice constitute a valuable tool for testing novel pharmacological agents against human FXII - an attractive potential target for antithrombotic therapy. Glycoprotein (GP)VI and C-type lectin-like receptor 2 (CLEC-2)-mediated (hem)immunoreceptor tyrosine-based activation motif (ITAM) signaling represent a major pathway for platelet activation. The last section of the thesis provides experimental evidence for redundant functions between the two members of the Grb2 family of adapter proteins - Grb2 and Gads that lie downstream of GPVI and CLEC-2 stimulation. In vitro and in vivo studies in mice deficient in both Grb2 and Gads (DKO) revealed that DKO platelets had defects in (hem)ITAM-stimulation-specific activation, aggregation and signal transduction that were more severe than the defects observed in single Grb2 KO or Gads KO mice. Furthermore, the specific role of these adapters downstream of (hem)ITAM signaling was essential for maintenance of hemostasis but dispensable for the known CLEC-2 dependent regulation of blood-lymphatic vessel separation.},
  subject      = {Blutgerinnung},
  language  = {en}
}
@phdthesis{Baur2019,
  author    = {Baur, Florentin Philipp},
  title     = {Establishment of a 3D tumour model and targeted therapy of BRAF-mutant colorectal cancer},
  doi       = {10.25972/OPUS-17412},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-174129},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Cancer remains after cardiovascular diseases the leading cause of death worldwide and an estimated 8.2 million people died of it in 2012. By 2030, 13 million cancer deaths are expected due to the growth and ageing of the population. Hereof, colorectal cancer (CRC) is the third most common cancer in men and the second in women with a wide geographical variation across the world. Usually, CRC begins as a non-cancerous growth leading to an adenomatous polyp, or adenoma, arising from glandular cells. Since research has brought about better understanding of the mechanisms of cancer development, novel treatments such as targeted therapy have emerged in the past decades. Despite that, up to 95\% of anticancer drugs tested in clinical phase I trials do not attain a market authorisation and hence these high attrition rates remain a key challenge for the pharmaceutical industry, making drug development processes enormously costly and inefficient. Therefore, new preclinical in vitro models which can predict drug responses in vivo more precisely are urgently needed. Tissue engineering not only provides the possibility of creating artificial three-dimensional (3D) in vitro tissues, such as functional organs, but also enables the investigation of drug responses in pathological tissue models, that is, in 3D cancer models which are superior to conventional two-dimensional (2D) cell cultures on petri dishes and can overcome the limitations of animal models, thereby reducing the need for preclinical in vivo models. In this thesis, novel 3D CRC models on the basis of a decellularised intestinal matrix were established. In the first part, it could be shown that the cell line SW480 exhibited different characteristics when grown in a 3D environment from those in conventional 2D culture. While the cells showed a mesenchymal phenotype in 2D culture, they displayed a more pronounced epithelial character in the 3D model. By adding stromal cells (fibroblasts), the cancer cells changed their growth pattern and built tumour-like structures together with the fibroblasts, thereby remodelling the natural mucosal structures of the scaffold. Additionally, the established 3D tumour model was used as a test system for treatment with standard chemotherapeutic 5-fluorouracil (5-FU). The second part of the thesis focused on the establishment of a 3D in vitro test system for targeted therapy. The US Food and Drug Administration has already approved of a number of drugs for targeted therapy of specific types of cancer. For instance, the small molecule vemurafenib (PLX4032, Zelboraf™) which demonstrated impressive response rates of 50-80\% in melanoma patients with a mutation of the rapidly accelerated fibrosarcoma oncogene type B (BRAF) kinase which belongs to the mitogen active protein kinase (MAPK) signalling pathway. However, only 5\% of CRC patients harbouring the same BRAF mutation respond to treatment with vemurafenib. An explanation for this unresponsiveness could be a feedback activation of the upstream EGFR, reactivating the MAPK pathway which sustains a proliferative signalling. To test this hypothesis, the two early passage cell lines HROC24 and HROC87, both presenting the mutation BRAF V600E but differing in other mutations, were used and their drug response to vemurafenib and/or gefitinib was assessed in conventional 2D cell culture and compared to the more advanced 3D model. Under 3D culture conditions, both cell lines showed a reduction of the proliferation rate only in the combination therapy approach. Furthermore, no significant differences between the various treatment approaches and the untreated control regarding apoptosis rate and viability for both cell lines could be found in the 3D tumour model which conferred an enhanced chemoresistance to the cancer cells. Because of the observed unresponsiveness to BRAF inhibition by vemurafenib as can be seen in the clinic for patients with BRAF mutations in CRC, the cell line HROC87 was used for further xenografting experiments and analysis of activation changes in the MAPK signalling pathway. It could be shown that the cells presented a reactivation of Akt in the 3D model when treated with both inhibitors, suggesting an escape mechanism for apoptosis which was not present in cells cultured under conventional 2D conditions. Moreover, the cells exhibited an activation of the hepatocyte growth factor receptor (HGFR, c-Met) in 2D and 3D culture, but this was not detectable in the xenograft model. This shows the limitations of in vivo models. The results suggest another feedback activation loop than that to the EGFR which might not primarily be involved in the resistance mechanism. This reflects the before mentioned high attrition rates in the preclinical drug testing.},
  subject      = {Dickdarmtumor},
  language  = {en}
}
@phdthesis{Beck2019,
  author    = {Beck, Sebastian},
  title     = {Using optogenetics to influence the circadian clock of \(Drosophila\) \(melanogaster\)},
  doi       = {10.25972/OPUS-18495},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-184952},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Almost all life forms on earth have adapted to the most impactful and most predictable recurring change in environmental condition, the cycle of day and night, caused by the axial rotation of the planet. As a result many animals have evolved intricate endogenous clocks, which adapt and synchronize the organisms' physiology, metabolism and behaviour to the daily change in environmental conditions. The scientific field researching these endogenous clocks is called chronobiology and has steadily grown in size, scope and relevance since the works of the earliest pioneers in the 1960s. The number one model organism for the research of circadian clocks is the fruit fly, Drosophila melanogaster, whose clock serves as the entry point to understanding the basic inner workings of such an intricately constructed endogenous timekeeping system. In this thesis it was attempted to combine the research on the circadian clock with the techniques of optogenetics, a fairly new scientific field, launched by the discovery of Channelrhodopsin 2 just over 15 years ago. Channelrhodopsin 2 is a light-gated ion channel found in the green alga Chlamydomonas reinhardtii. In optogenetics, researches use these light-gated ion channels like Channelrhodopsin 2 by heterologously expressing them in cells and tissues of other organisms, which can then be stimulated by the application of light. This is most useful when studying neurons, as these channels provide an almost non-invasive tool to depolarize the neuronal plasma membranes at will. The goal of this thesis was to develop an optogenetic tool, which would be able to influence and phase shift the circadian clock of Drosophila melanogaster upon illumination. A phase shift is the adaptive response of the circadian clock to an outside stimulus that signals a change in the environmental light cycle. An optogenetic tool, able to influence and phase shift the circadian clock predictably and reliably, would open up many new ways and methods of researching the neuronal network of the clock and which neurons communicate to what extent, ultimately synchronizing the network. The first optogenetic tool to be tested in the circadian clock of Drosophila melanogaster was ChR2-XXL, a channelrhodopsin variant with dramatically increased expression levels and photocurrents combined with a prolonged open state. The specific expression of ChR2-XXL and of later constructs was facilitated by deploying the three different clock-specific GAL4-driver lines, clk856-gal4, pdf-gal4 and mai179-gal4. Although ChR2-XXL was shown to be highly effective at depolarizing neurons, these stimulations proved to be unable to significantly phase shift the circadian clock of Drosophila. The second series of experiments was conducted with the conceptually novel optogenetic tools Olf-bPAC and SthK-bPAC, which respectively combine a cyclic nucleotide-gated ion channel (Olf and SthK) with the light-activated adenylyl-cyclase bPAC. These tools proved to be quite useful when expressed in the motor neurons of instar-3 larvae of Drosophila, paralyzing the larvae upon illumination, as well as affecting body length. This way, these new tools could be precisely characterized, spawning a successfully published research paper, centered around their electrophysiological characterization and their applicability in model organisms like Drosophila. In the circadian clock however, these tools caused substantial damage, producing severe arrhythmicity and anomalies in neuronal development. Using a temperature-sensitive GAL80-line to delay the expression until after the flies had eclosed, yielded no positive results either. The last series of experiments saw the use of another new series of optogenetic tools, modelled after the Olf-bPAC, with bPAC swapped out for CyclOp, a membrane-bound guanylyl-cyclase, coupled with less potent versions of the Olf. This final attempt however also ended up being unsuccessful. While these tools could efficiently depolarize neuronal membranes upon illumination, they were ultimately unable to stimulate the circadian clock in way that would cause it to phase shift. Taken together, these mostly negative results indicate that an optogenetic manipulation of the circadian clock of Drosophila melanogaster is an extremely challenging subject. As light already constitutes the most impactful environmental factor on the circadian clock, the combination of chronobiology with optogenetics demands the parameters of the conducted experiments to be tuned with an extremely high degree of precision, if one hopes to receive positive results from these types of experiments at all.},
  subject      = {Chronobiologie},
  language  = {en}
}
@article{BeerSchenkHelfrichFoersteretal.2019,
  author    = {Beer, Katharina and Schenk, Mariela and Helfrich-F{\"o}rster, Charlotte and Holzschuh, Andrea},
  title     = {The circadian clock uses different environmental time cues to synchronize emergence and locomotion of the solitary bee Osmia bicornis},
  series = {Scientific Reports},
  volume    = {9},
  journal   = {Scientific Reports},
  doi       = {10.1038/s41598-019-54111-3},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-202721},
  pages     = {17748},
  year      = {2019},
  abstract  = {Life on earth adapted to the daily reoccurring changes in environment by evolving an endogenous circadian clock. Although the circadian clock has a crucial impact on survival and behavior of solitary bees, many aspects of solitary bee clock mechanisms remain unknown. Our study is the first to show that the circadian clock governs emergence in Osmia bicornis, a bee species which overwinters as adult inside its cocoon. Therefore, its eclosion from the pupal case is separated by an interjacent diapause from its emergence in spring. We show that this bee species synchronizes its emergence to the morning. The daily rhythms of emergence are triggered by temperature cycles but not by light cycles. In contrast to this, the bee's daily rhythms in locomotion are synchronized by light cycles. Thus, we show that the circadian clock of O. bicornis is set by either temperature or light, depending on what activity is timed. Light is a valuable cue for setting the circadian clock when bees have left the nest. However, for pre-emerged bees, temperature is the most important cue, which may represent an evolutionary adaptation of the circadian system to the cavity-nesting life style of O. bicornis.},
  language  = {en}
}